This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).
From 1 January 2022, the listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.
This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).
Published 16 December 2021 Last updated 18 September 2023 +show all updates
Added to the list: Spikevax XBB.1.5 COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vials.
Added Nelarabine 5mg/ml solution for infusion to the list.
Added: Fluorouracil 5g/100ml solution for infusion vials and Fluorouracil 2.5g/50ml solution for infusion vials. Removed: NovoRapid FlexPen 100units/ml solution for injection 3ml pre-filled pens.
Added to the list:Leflunomide 10mg tablets;Ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes;Dacarbazine 500mg powder for solution for infusion vials.
Added the following products to the list: Semaglutide 0.25 in 0.37ml solution for injection in a prefilled device; Semaglutide 0.5mg in 0.37ml solution for injection in a prefilled device; Semaglutide 1mg in 0.75ml solution for injection in a prefilled device; Semaglutide 1.7mg in 0.75ml solution for injection in a prefilled device; Semaglutide 2.4mg in 0.75ml solution for injection in a prefilled device; and Novomix 30 FlexPen 100units/ml solution for injection 3ml pre-filled pens (Insulin aspart biphasic 30/70 100units/ml suspension for injection 3ml pre-filled disposable devices).
Added:HyQvia 20g/200ml solution for infusion and 10ml vials - Normal immunoglobulin human 20g/200ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 10ml vials and; Xultophy 100units/ml / 3.6mg/ml solution for injection 3ml pre-filled pens - Insulin degludec 100units/ml / Liraglutide 3.6mg/ml solution for injection 3ml pre-filled disposable devices.
Added to the list: Aprepitant 125mg oral powder sachets; Acetylcholine chloride 20mg powder and solvent for solution for intraocular irrigation ampoules; Omalizumab 75mg/0.5ml solution for injection pre-filled syringes; Doxorubicin 50mg/25ml solution for injection vials; Doxorubicin 10mg/5ml solution for injection vials. Removed from the list: Fondaparinux sodium 5mg/0.4ml solution for injection pre-filled syringes; Toujeo 300units/ml solution for injection 3ml pre-filled DoubleStar pens - Insulin glargine 300units/ml solution for injection 3ml pre-filled disposable devices; Kiovig 20g/200ml solution for infusion vials - Normal immunoglobulin human 20g/200ml solution for infusion vials; Kiovig 5g/50ml solution for infusion vials - Normal immunoglobulin human 5g/50ml solution for infusion vials; Adempas 2.5mg tablets - Riociguat 2.5mg tablets; Senna fruit 12.4% / Ispaghula 54.2% granules; Omalizumab 150mg/1ml solution for injection pre-filled syringes.
Added to the list: (Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials) Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials.
Added to the list:Oxaliplatin 100mg/20ml concentrate for solution for infusion vials; Oxaliplatin 200mg/40ml concentrate for solution for infusion vials; Oxaliplatin 50mg/10ml concentrate for solution for infusion vials.
The following product was added to the list: Voriconazole 200mg/5ml oral suspension. Removed from the
